KCNJ10 and myeloid sarcoma: In line with this, we analyzed the gene bank (GSE180759) uploaded from a previous human MS study,[61] which showed that the expression of the kcnj10 gene was significantly decreased in OPCs of MS patients compared to samples from healthy controls (Mann–Whitney test, p = 0.0357).